HM Payson & Co’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $13.3K | Hold |
1,700
| – | – | ﹤0.01% | 839 |
|
|
2024
Q4 | $25.3K | Hold |
1,700
| – | – | ﹤0.01% | 745 |
|
|
2024
Q3 | $26K | Hold |
1,700
| – | – | ﹤0.01% | 730 |
|
|
2024
Q2 | $25.9K | Hold |
1,700
| – | – | ﹤0.01% | 718 |
|
|
2024
Q1 | $32.1K | Hold |
1,700
| – | – | ﹤0.01% | 674 |
|
|
2023
Q4 | $32.5K | Hold |
1,700
| – | – | ﹤0.01% | 661 |
|
|
2023
Q3 | $30.5K | Hold |
1,700
| – | – | ﹤0.01% | 667 |
|
|
2023
Q2 | $34.5K | Hold |
1,700
| – | – | ﹤0.01% | 646 |
|
|
2023
Q1 | $31K | Hold |
1,700
| – | – | ﹤0.01% | 653 |
|
|
2022
Q4 | $35.2K | Hold |
1,700
| – | – | ﹤0.01% | 607 |
|
|
2022
Q3 | $44K | Buy |
1,700
+700
| +70% | +$18.1K | ﹤0.01% | 593 |
|
|
2022
Q2 | $25K | Buy |
+1,000
| New | +$25K | ﹤0.01% | 682 |
|